Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$417,906
in 7 filings

Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-14 Garcia-Parada Carlos Chief Financial Officer Grant or award · Stock Option (Right to Buy) +54,006 54,006
2022-02-14 Garcia-Parada Carlos Chief Financial Officer Grant or award · Restricted Stock Units +17,322 17,322
2021-09-13 Garcia-Parada Carlos Chief Financial Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2021-01-04 Garcia-Parada Carlos Chief Financial Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000

Page 1 of 1 · 4 trades